Medicare Advantage contract

S4802 Wellcare

Medicare Prescription Drug Plan · Parent: Centene Corporation

Latest enrollment
7,689,240
2025-01
Year-over-year
+24.0%
contract book
National MA share
+13.4%
rank #1 of 936
Overall stars (latest)
summary rating

Enrollment trend · 5 years

01.9M3.8M5.8M7.7M202120222023202420257.7MReported

Star rating history

YearOverallPart CPart DΔ
2020 3.5
2021 4.0
2022 3.5
2023 3.0
2024 4.0

Premium

PlanYearMonthly premiumPart D premium
S4802-012 2026 $nan $6.70
S4802-013 2026 $nan $0.00
S4802-014 2026 $nan $5.70
S4802-020 2026 $nan $0.00
S4802-021 2026 $nan $23.70
S4802-069 2026 $nan $0.00
S4802-070 2026 $nan $9.70
S4802-071 2026 $nan $3.70
S4802-072 2026 $nan $10.70
S4802-073 2026 $nan $0.00
S4802-074 2026 $nan $0.00
S4802-075 2026 $nan $0.00

Showing 12 of 68 plans under this contract.

Premium analytics

Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.

Measure-level star movers

2023 → 2024

7 measures moved — 4 ↑ · 3 ↓

  • D07 MPF Price Accuracy 3★ → 1★
  • D01 Call Center – Foreign Language Interpreter and TTY Availability 3★ → 5★
  • D04 Drug Plan Quality Improvement 2★ → 4★
  • D09 Medication Adherence for Hypertension (RAS antagonists) 2★ → 3★
  • D03 Members Choosing to Leave the Plan 4★ → 3★
  • D12 Statin Use in Persons with Diabetes (SUPD) 3★ → 2★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and projected next-year exposure. Talk to us →

County enrollment

0 counties
StateCountyEnrollment
🔒

Want a custom analysis on this?

Talk to us →

County market share vs. competitors

service-area overlap

Head-to-head share by county against named competitors, with expansion whitespace and defended turf.

🔒

Want a custom analysis on this?

Talk to us →